Overview

Risperidone Treatment in Dually-Diagnosed Individuals - 2

Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
New York State Psychiatric Institute
Treatments:
Risperidone
Criteria
Please contact site for information.